Phillippe Mark, Bradley Diana F, Phillippe Kathrynn, Engle Daniel
Department of Obstetrics and Gynecology, University of Vermont College of Medicine, Burlington, Vermont 05405, USA.
J Soc Gynecol Investig. 2006 Oct;13(7):477-82. doi: 10.1016/j.jsgi.2006.07.009.
Fgl2 and thrombin potentially play roles during inflammation-induced preterm delivery. These studies sought to demonstrate functional prothrombinase enzyme activity in rat uterus, consistent with the expression of Fgl2 in this tissue.
Myometrial and other tissue obtained from non-pregnant and timed-pregnant rats was homogenized in Tris-buffered saline. Prothrombinase activity was determined based on the kinetic metabolism of a chromogenic thrombin substrate. Homogenates were incubated with prothrombin followed by the addition of the thrombin substrate. Thrombin activity was determined by comparing tissue activity to a standard curve generated using 0.01 to 0.04 units of active thrombin. Western blot studies were also performed to confirm tissue prothrombinase activity in myometrial homogenates. Prothrombin was incubated with tissue homogenates; the reactions were then terminated with sodium dodecyl sulfate (SDS) loading buffer.
Prothrombinase activity in myometrial tissue was observed to be 0.047 to 0.077 U thrombin/10 min/microg protein. Heat denaturation and calcium removal eliminated prothrombinase activity, whereas the addition of Factor V enhanced activity. The Western blots confirmed the presence of prothrombin, the anticipated prethrombin fragments, and thrombin. Consistent with the enzyme studies, the thrombin band formed upon incubation with myometrial homogenates from pregnant and nonpregnant rats. In contrast, the thrombin band was not apparent with removal of calcium, heat denaturation and treatment with serine protease inhibitors.
In summary, these studies have confirmed functionally active prothrombinase activity in rat myometrium, supporting the hypothesis that Fgl2 is expressed in this tissue.
Fgl2和凝血酶可能在炎症诱导的早产过程中发挥作用。这些研究旨在证明大鼠子宫中存在功能性凝血酶原酶活性,这与该组织中Fgl2的表达一致。
从未怀孕和定时怀孕的大鼠获取子宫肌层及其他组织,在Tris缓冲盐溶液中匀浆。基于发色底物凝血酶的动力学代谢测定凝血酶原酶活性。匀浆与凝血酶原孵育,随后加入凝血酶底物。通过将组织活性与使用0.01至0.04单位活性凝血酶生成的标准曲线进行比较来测定凝血酶活性。还进行了蛋白质印迹研究以确认子宫肌层匀浆中的组织凝血酶原酶活性。凝血酶与组织匀浆孵育;然后用十二烷基硫酸钠(SDS)上样缓冲液终止反应。
观察到子宫肌层组织中的凝血酶原酶活性为0.047至0.077 U凝血酶/10分钟/微克蛋白质。热变性和去除钙消除了凝血酶原酶活性,而添加因子V则增强了活性。蛋白质印迹证实了凝血酶原、预期的凝血酶原片段和凝血酶的存在。与酶研究一致,与怀孕和未怀孕大鼠的子宫肌层匀浆孵育后形成了凝血酶条带。相比之下,去除钙、热变性和用丝氨酸蛋白酶抑制剂处理后,凝血酶条带不明显。
总之,这些研究证实了大鼠子宫肌层中存在功能活跃的凝血酶原酶活性,支持了Fgl2在该组织中表达的假说。